NZ277605A - Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861 - Google Patents

Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861

Info

Publication number
NZ277605A
NZ277605A NZ277605A NZ27760597A NZ277605A NZ 277605 A NZ277605 A NZ 277605A NZ 277605 A NZ277605 A NZ 277605A NZ 27760597 A NZ27760597 A NZ 27760597A NZ 277605 A NZ277605 A NZ 277605A
Authority
NZ
New Zealand
Prior art keywords
polypeptide
atcc
rna
dna
derived
Prior art date
Application number
NZ277605A
Inventor
Henrik S Olsen
Robert D Fleishmann
Original Assignee
Human Genomes Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genomes Sciences Inc filed Critical Human Genomes Sciences Inc
Publication of NZ277605A publication Critical patent/NZ277605A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ277605A 1994-11-10 1997-05-29 Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861 NZ277605A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/013206 WO1996015147A1 (en) 1994-11-10 1994-11-10 Human stanniocalcin-alpha

Publications (1)

Publication Number Publication Date
NZ277605A true NZ277605A (en) 1999-03-29

Family

ID=22243284

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ277605A NZ277605A (en) 1994-11-10 1997-05-29 Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861

Country Status (6)

Country Link
EP (1) EP0797592A4 (en)
JP (1) JPH10509036A (en)
KR (1) KR100432260B1 (en)
AU (1) AU687962B2 (en)
NZ (1) NZ277605A (en)
WO (1) WO1996015147A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008322A (en) * 1996-04-02 1999-12-28 Zymogenetics, Inc. Stanniocalcin-2
US6538119B2 (en) * 1997-11-18 2003-03-25 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US7252973B1 (en) * 1998-04-10 2007-08-07 Daiichi Pharmaceutical Co., Ltd. Protein and processes for producing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius
US5837498A (en) * 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin

Also Published As

Publication number Publication date
KR970707155A (en) 1997-12-01
JPH10509036A (en) 1998-09-08
EP0797592A4 (en) 1999-10-20
KR100432260B1 (en) 2004-09-16
WO1996015147A1 (en) 1996-05-23
EP0797592A1 (en) 1997-10-01
AU1289695A (en) 1996-06-06
AU687962B2 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
EP0910408A4 (en) DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF
GB9414925D0 (en) Electrode and preparation thereof
AU8264898A (en) Human jagged polypeptide, encoding nucleic acids and methods of use
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
ZA964733B (en) Ob protein compositions and methods
IL134068A (en) Mammalian cytokine: interleukin - b 30 and isolated polunucleotides encoding the same
ZA962245B (en) Dna encoding human papillomavirus type 18
GB9310472D0 (en) Phenylalanine-free protein and dna coding thereof
EP0948651A4 (en) Recombinant n-smases and nucleic acids encoding same
HK1010153A1 (en) Recombinant human alpha-fetoprotein and uses thereof.
EP0681826A3 (en) Heat-safe hair preparation and method of using same.
HUT77108A (en) Dna sequence and its use
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
EP0731164A4 (en) HUMAN PHOSPHOLIPASE C-alpha AND DNA SEQUENCE CODING FOR THE SAME
NZ277605A (en) Human stanniocalcin-alpha polypeptide and dna (rna) encoding polypeptide; polypeptide may be derived from atcc 75861
GB9423372D0 (en) Proteins and their uses
ZA9510154B (en) Chimeric proteins having fibrinolytic and thrombin-inhibing properties
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
EP0783510A4 (en) Human potassium channel 1 and 2 proteins
EP0729975A4 (en) Ecdn protein and dna coding for the same
EP0692537A3 (en) Recombinant gibberellin DNA and uses thereof
IL128746A0 (en) Ptx-sensitive g proteins their preparation and use
GB9606272D0 (en) Gene and peptides

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)